KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Teva Pharmaceutical Industries (TEVA) Income from Continuing Operations (2016 - 2026)

Teva Pharmaceutical Industries filings provide 18 years of Income from Continuing Operations readings, the most recent being 370000000.0 for Q1 2026.

  • On a quarterly basis, Income from Continuing Operations rose 68.18% to 370000000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was 1553000000.0, a 217.3% increase, with the full-year FY2025 number at 1403000000.0, up 171.58% from a year prior.
  • Income from Continuing Operations hit 370000000.0 in Q1 2026 for Teva Pharmaceutical Industries, down from 470000000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 519000000.0 in Q1 2024 to a low of 1334000000.0 in Q4 2022.
  • Median Income from Continuing Operations over the past 5 years was 64000000.0 (2022), compared with a mean of 140647058.82.
  • Biggest five-year swings in Income from Continuing Operations: plummeted 1286.59% in 2022 and later skyrocketed 305.14% in 2024.
  • Teva Pharmaceutical Industries' Income from Continuing Operations stood at 1334000000.0 in 2022, then surged by 134.93% to 466000000.0 in 2023, then tumbled by 159.01% to 275000000.0 in 2024, then soared by 270.91% to 470000000.0 in 2025, then decreased by 21.28% to 370000000.0 in 2026.
  • The last three reported values for Income from Continuing Operations were 370000000.0 (Q1 2026), 470000000.0 (Q4 2025), and 432000000.0 (Q3 2025) per Business Quant data.